NasdaqGM - Delayed Quote USD
Gain Therapeutics, Inc. (GANX)
1.8500
0.0000
(0.00%)
At close: April 23 at 4:00:01 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ALDER MATTHIAS Chief Executive Officer | Conversion of Exercise of derivative security | Mar 26, 2024 | 21,140 |
| ISLAM KHALID Officer and Director | Purchase | Aug 9, 2024 | 930,784 |
| MACK GENE C Chief Executive Officer | Purchase | Aug 9, 2024 | 14,400 |
| RICHMAN ERIC I. Director | Purchase | Jul 1, 2024 | 304,458 |
| RILEY JEFFREY SCOTT Director | Purchase | Mar 28, 2024 | 30,000 |
Related Tickers
COYA Coya Therapeutics, Inc.
6.56
-1.20%
INMB INmune Bio, Inc.
8.24
+5.10%
PYPD PolyPid Ltd.
2.7500
+0.36%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
FENC Fennec Pharmaceuticals Inc.
5.65
+3.86%
AVIR Atea Pharmaceuticals, Inc.
2.8500
-0.70%
CRVS Corvus Pharmaceuticals, Inc.
3.5200
+5.71%
ERAS Erasca, Inc.
1.4200
+2.90%
TERN Terns Pharmaceuticals, Inc.
2.8800
+2.86%
ARTV Artiva Biotherapeutics, Inc.
2.4500
0.00%